Literature DB >> 12911602

Anticoagulation with warfarin downregulates inflammation.

P S Maclean, R C Tait, A Rumley, A D McMahon, G D Lowe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12911602     DOI： 10.1046/j.1538-7836.2003.t01-1-00372.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  9 in total

1.  Multivessel myocardial infarction: a window to future treatments of myocardial infarction.

Authors:  Philip D Houck; Walter J Linz
Journal:  Heart Asia       Date:  2010-08-26

2.  New direction for medical research.

Authors:  Philip D Houck
Journal:  Heart Asia       Date:  2010-09-18

3.  Determination of Pleiotropic Effect of Warfarin in VKORC1 and CYP2C9 Genotypes in Patients With Heart Valve Replacement.

Authors:  Huma Shafique; Naeem Mahmood Ashraf; Amir Rashid; Asifa Majeed; Tayyaba Afsar; Ann K Daly; Ali Almajwal; Nawaf W Alruwaili; Azmat Ullah Khan; Suhail Razak
Journal:  Front Cardiovasc Med       Date:  2022-06-10

Review 4.  Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants.

Authors:  Anke C Fender; Reza Wakili; Dobromir Dobrev
Journal:  Pharmacol Res       Date:  2019-05-02       Impact factor: 7.658

5.  Elevated International Normalized Ratio Is Associated With Ruptured Aneurysms.

Authors:  Anil Can; Victor M Castro; Dmitriy Dligach; Sean Finan; Sheng Yu; Vivian Gainer; Nancy A Shadick; Guergana Savova; Shawn Murphy; Tianxi Cai; Scott T Weiss; Rose Du
Journal:  Stroke       Date:  2018-09       Impact factor: 7.914

6.  VKORC1 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy: transthyretin precursor as a potential biomarker.

Authors:  Ramasamy Saminathan; Jing Bai; Laleh Sadrolodabaee; Govindasamy Muralidharan Karthik; Onkar Singh; Koilan Subramaniyan; Chi Bun Ching; Wei Ning Chen; Balram Chowbay
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

7.  Tissue factor, blood coagulation, and beyond: an overview.

Authors:  Arthur J Chu
Journal:  Int J Inflam       Date:  2011-09-20

8.  Arrhythmia Recurrence After Atrial Fibrillation Ablation: Impact of Warfarin vs. Non-Vitamin K Antagonist Oral Anticoagulants.

Authors:  Songnan Wen; Cristina Pislaru; Kristi H Monahan; Stephanie M Barnes; David O Hodge; Douglas L Packer; Sorin V Pislaru; Samuel J Asirvatham
Journal:  Cardiovasc Drugs Ther       Date:  2021-05-18       Impact factor: 3.947

9.  Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study.

Authors:  Lisa Eggebrecht; Jürgen H Prochaska; Andreas Schulz; Natalie Arnold; Claus Jünger; Sebastian Göbel; Dagmar Laubert-Reh; Harald Binder; Manfred E Beutel; Nobert Pfeiffer; Stefan Blankenberg; Karl J Lackner; Henri M Spronk; Hugo Ten Cate; Thomas Münzel; Philipp S Wild
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.